To compare the efficacy and safety of circumferential pulmonary vein isolation without
contact force with the pulmonary vein antrum modification for patients of paroxysmal atrial
Procedure: pulmonary vein antrum modification
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT03026413
Ages eligible for Study
18 Years to 75 Years
Genders eligible for Study
Accepts Healthy Volunteers
patients with paroxysmal atrial fibrillation refractory to drugs
history of cardiac surgery
valvular heart disease
abnormal thyroid function
left atrial thrombus
All locations for NCT03026413
View full eligibility
Tris trial is registered with FDA with number: NCT03026413. The sponsor of the trial is The First Affiliated Hospital with Nanjing Medical University and it is looking for 180 volunteers for the current phase.
Official trial title: The Comparison Between the Pulmonary Vein Antrum Modification by SmartTouch Ablation Catheter With Contact Force Monitoring and Circumferential Pulmonary Vein Isolation by That Without Contact Force Monitoring Plus Lasso Catheter for the Patients of Paroxysmal Atrial Fibrillation: a Randomized Controlled Trial
Thank you for applying!
We'll contact you soon with more information.
FindMeCure is constantly improving its search. Take part in it and help millions by filling our patients' survey!